Abiopharma

Clinical trial NCT06450197: primary completion date: 2026-05-01 → 2026-04-30.

Clinical trial NCT06018337 updates: 1. completion date: 2028-07-01 → 2028-08-01 2. primary completion date: 2026-05-01 → 2026-06-01

Arch Capital Group Ltd. Announces Cash Tender Offers to Purchase up to a Capped Amount of Certain of Its Subsidiaries’ Debt Securities

Notification from Dominari Holdings Inc

RenX Posts Record Delivery Quarter at Myakka City, Up 57%; Independent Drone Survey Verifies Approximately 185,000 Cubic Yards On-Site

$170 Billion in Border and Security Funding Highlights Growing Demand for AI-Powered Surveillance and Machine Vision Technologies

Corsica Utility to Support Its Conservation Goals With Itron’s Smart Water Solution

Net Asset Value(s)

Envirotech Vehicles, Inc. (NASDAQ: EVTV) Builds out 500 MW Energy-Backed Infrastructure Platform Across 548-Acre Campus to Power Artificial Intelligence and Data Center Growth

Genius Group Completes First Investments for its AI Treasury with Pre-IPO exposure to SpaceX, Anthropic and OpenAI